Roth/MKM Starts Reviva Pharmaceuticals (RVPH) at Buy

January 10, 2025 4:59 AM EST Send to a Friend
(Updated - January 10, 2025 9:00 AM EST)

Roth/MKM analyst Boobalan Pachaiyappan initiates coverage on Reviva Pharmaceuticals (NASDAQ: RVPH) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login